We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARMK icon
1276
Aramark
ARMK
$14.7B
-1,204,230
Closed -$37.9M
ASC icon
1277
Ardmore Shipping
ASC
$683M
-124,912
Closed -$836K
EFOR
1278
Everforth Inc
EFOR
$1.32B
-21,860
Closed -$1.37M
CVSA
1279
Covista Inc
CVSA
$4.8B
-751
Closed -$29K
AXDX
1280
DELISTED
Accelerate Diagnostics
AXDX
-1,349
Closed -$251K
AXGN icon
1281
Axogen
AXGN
$2.5B
-9,465
Closed -$118K
AXTI icon
1282
AXT Inc
AXTI
$5.8B
-3,021
Closed -$11K
AZZ icon
1283
AZZ Inc
AZZ
$4.54B
-999
Closed -$44K
BAH icon
1284
Booz Allen Hamilton
BAH
$9.15B
-3,522
Closed -$250K
BALY icon
1285
Bally's
BALY
$658M
-50,357
Closed -$1.15M
BAX icon
1286
Baxter International
BAX
$14.2B
-58,389
Closed -$5.11M
BBIO icon
1287
BridgeBio Pharma
BBIO
$16.5B
-15,707
Closed -$337K
BBU
1288
DELISTED
Brookfield Business Partners
BBU
-31,472
Closed -$792K
BBVA icon
1289
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
-129,785
Closed -$675K
BBWI icon
1290
Bath & Body Works
BBWI
$4.1B
-138,705
Closed -$2.2M
BEDU
1291
DELISTED
Bright Scholar Education Holdings
BEDU
-1,400
Closed -$54K
BEP icon
1292
Brookfield Renewable
BEP
$9.96B
-6,755
Closed -$146K
BFH icon
1293
Bread Financial
BFH
$4.38B
-119,737
Closed -$12.2M
BIO icon
1294
Bio-Rad Laboratories Class A
BIO
$9.42B
-12,109
Closed -$4.03M
BJRI icon
1295
BJ's Restaurants
BJRI
$1.48B
-462,484
Closed -$18M
BKD icon
1296
Brookdale Senior Living
BKD
$3.4B
-55,161
Closed -$418K
BKNG icon
1297
Booking.com
BKNG
$161B
-238,450
Closed -$18.7M
BL icon
1298
BlackLine
BL
$1.72B
-16,312
Closed -$780K
BLMN icon
1299
Bloomin' Brands
BLMN
$938M
-68,689
Closed -$1.3M
BMI icon
1300
Badger Meter
BMI
$4.03B
-546
Closed -$29K

Similar funds

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.